BG107554A - Производни на аминоалкоксибензоил-бензофуран или бензотиофен, метод за получаването им и състави, които ги съдържат - Google Patents
Производни на аминоалкоксибензоил-бензофуран или бензотиофен, метод за получаването им и състави, които ги съдържат Download PDFInfo
- Publication number
- BG107554A BG107554A BG107554A BG10755403A BG107554A BG 107554 A BG107554 A BG 107554A BG 107554 A BG107554 A BG 107554A BG 10755403 A BG10755403 A BG 10755403A BG 107554 A BG107554 A BG 107554A
- Authority
- BG
- Bulgaria
- Prior art keywords
- group
- alkali metal
- formula
- compound
- benzofuran
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0010833A FR2813308B1 (fr) | 2000-08-23 | 2000-08-23 | Aminoalkoxybenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation ainsi que les compositions les contenant |
PCT/FR2001/002657 WO2002016340A1 (fr) | 2000-08-23 | 2001-08-23 | Aminoalkoxybenzoyl-benzofuranes ou benzothiophenes, leur procede de preparation et les compositions les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
BG107554A true BG107554A (bg) | 2003-11-28 |
Family
ID=8853673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG107554A BG107554A (bg) | 2000-08-23 | 2003-02-13 | Производни на аминоалкоксибензоил-бензофуран или бензотиофен, метод за получаването им и състави, които ги съдържат |
Country Status (26)
Country | Link |
---|---|
US (1) | US7148240B2 (sk) |
EP (1) | EP1315710B1 (sk) |
JP (1) | JP5140226B2 (sk) |
KR (1) | KR20030023769A (sk) |
CN (1) | CN1471520A (sk) |
AT (1) | ATE360625T1 (sk) |
AU (1) | AU2001286003A1 (sk) |
BG (1) | BG107554A (sk) |
BR (1) | BR0113347A (sk) |
CA (1) | CA2415852A1 (sk) |
CZ (1) | CZ2003525A3 (sk) |
DE (1) | DE60128112T2 (sk) |
EA (1) | EA005825B1 (sk) |
FR (1) | FR2813308B1 (sk) |
HU (1) | HUP0302961A3 (sk) |
IL (1) | IL153959A0 (sk) |
IS (1) | IS6675A (sk) |
MA (1) | MA26942A1 (sk) |
MX (1) | MXPA03001536A (sk) |
NO (1) | NO20030802L (sk) |
NZ (1) | NZ523724A (sk) |
OA (1) | OA12360A (sk) |
PL (1) | PL362131A1 (sk) |
SK (1) | SK2122003A3 (sk) |
WO (1) | WO2002016340A1 (sk) |
ZA (1) | ZA200300922B (sk) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10129119B4 (de) * | 2001-06-16 | 2007-10-04 | Schwarz Pharma Ag | Kristalline Salze von Benzoylbenzofuran-Derivaten, insbesondere von[2-(4-{1-[2-((S)-sec.-Butoxycarbonylmethyl)-benzofuran-3-carbonyl]-methanoyl}-2,6-diiod-phenoxy)-ethyl]-diethylamino und [2-(4-{1-[(3-Methyl-2-(S)-Butoxycarbonylmethyl)-benzofuran-3-carbonyl]- methanoyl}-2,6-diiodphenoxy)-ethyl]-diethylamino, deren Verwendung und Herstellung sowie diese Salze enthaltende Arzneimittel |
ATE555091T1 (de) | 2006-02-03 | 2012-05-15 | Bionomics Ltd | Substituierte benzofurane, benzothiophene, benzoselenophene und indole und ihre verwendung als tubulinpolymerisationsinhibitoren |
FR2958290B1 (fr) | 2010-03-30 | 2012-10-19 | Sanofi Aventis | Procede de preparation de derives de sulfonamido-benzofurane |
HUP1000330A2 (en) | 2010-06-18 | 2011-12-28 | Sanofi Sa | Process for the preparation of dronedarone and the novel intermediates |
AU2011202542A1 (en) | 2010-07-14 | 2012-02-02 | Indian Institute Of Science | Benzothiophene carboxamide compounds, composition and applications thereof |
FR2963006B1 (fr) * | 2010-07-21 | 2013-03-15 | Sanofi Aventis | Procede de preparation de derives de nitro-benzofurane |
HUP1100167A2 (en) | 2011-03-29 | 2012-11-28 | Sanofi Sa | Process for preparation of dronedarone by mesylation |
HUP1100165A2 (en) | 2011-03-29 | 2012-12-28 | Sanofi Sa | Process for preparation of dronedarone by n-butylation |
FR2983198B1 (fr) | 2011-11-29 | 2013-11-15 | Sanofi Sa | Procede de preparation de derives de 5-amino-benzoyl-benzofurane |
EP2617718A1 (en) | 2012-01-20 | 2013-07-24 | Sanofi | Process for preparation of dronedarone by the use of dibutylaminopropanol reagent |
WO2013121235A2 (en) * | 2012-02-13 | 2013-08-22 | Sanofi | Process for preparation of dronedarone by removal of hydroxyl group |
US9249119B2 (en) | 2012-02-14 | 2016-02-02 | Sanofi | Process for the preparation of dronedarone by oxidation of a sulphenyl group |
US9382223B2 (en) | 2012-02-22 | 2016-07-05 | Sanofi | Process for preparation of dronedarone by oxidation of a hydroxyl group |
US9238636B2 (en) | 2012-05-31 | 2016-01-19 | Sanofi | Process for preparation of dronedarone by Grignard reaction |
CN114736181B (zh) * | 2022-04-28 | 2024-03-08 | 河南大学 | 可见光介导的酰基化苯并呋喃衍生物的合成方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3248401A (en) * | 1966-04-26 | Diethylaminoe hoxybenzoyl benzofurans | ||
US4024273A (en) * | 1974-06-20 | 1977-05-17 | Smithkline Corporation | Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity |
US4851554A (en) * | 1987-04-06 | 1989-07-25 | University Of Tennessee Research Corporation | Certain 3-substituted 2-alkyl benzofuran derivatives |
US4806663A (en) * | 1987-04-06 | 1989-02-21 | The University Of Tennessee Research Corporation | Certain 3-substituted 2-alkyl benzofuran derivatives |
US4831054A (en) * | 1988-04-18 | 1989-05-16 | Taro Pharmaceuticals, Ltd. | 2-Alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia |
AT391316B (de) * | 1988-09-15 | 1990-09-25 | Ebewe Arzneimittel | Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
FR2665444B1 (fr) * | 1990-08-06 | 1992-11-27 | Sanofi Sa | Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant. |
US5482949A (en) * | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
US5364880A (en) * | 1993-06-16 | 1994-11-15 | Advanced Therapies, Inc. | Compound for treatment of cardiac arrhythmia, synthesis, and methods of use |
US6756388B1 (en) * | 1993-10-12 | 2004-06-29 | Pfizer Inc. | Benzothiophenes and related compounds as estrogen agonists |
FR2735365B1 (fr) * | 1995-06-14 | 1997-09-05 | Sanofi Sa | Utilisation d'un antagoniste de l'angiotensine ii et d'un derive du benzofurane pour la preparation d'un medicament utile dans le traitement des affections cardiovasculaires |
CA2217373A1 (en) * | 1996-10-10 | 1998-04-10 | Michael John Martin | Benzo¬b|thiophene compounds, intermediates, formulations, and methods |
-
2000
- 2000-08-23 FR FR0010833A patent/FR2813308B1/fr not_active Expired - Fee Related
-
2001
- 2001-08-23 JP JP2002521441A patent/JP5140226B2/ja not_active Expired - Fee Related
- 2001-08-23 PL PL01362131A patent/PL362131A1/xx not_active Application Discontinuation
- 2001-08-23 AT AT01965342T patent/ATE360625T1/de not_active IP Right Cessation
- 2001-08-23 AU AU2001286003A patent/AU2001286003A1/en not_active Abandoned
- 2001-08-23 CA CA002415852A patent/CA2415852A1/fr not_active Abandoned
- 2001-08-23 DE DE60128112T patent/DE60128112T2/de not_active Expired - Lifetime
- 2001-08-23 BR BR0113347-0A patent/BR0113347A/pt not_active IP Right Cessation
- 2001-08-23 OA OA1200300036A patent/OA12360A/fr unknown
- 2001-08-23 IL IL15395901A patent/IL153959A0/xx unknown
- 2001-08-23 KR KR10-2003-7002620A patent/KR20030023769A/ko not_active Application Discontinuation
- 2001-08-23 US US10/362,138 patent/US7148240B2/en not_active Expired - Lifetime
- 2001-08-23 NZ NZ523724A patent/NZ523724A/en unknown
- 2001-08-23 EP EP01965342A patent/EP1315710B1/fr not_active Expired - Lifetime
- 2001-08-23 WO PCT/FR2001/002657 patent/WO2002016340A1/fr not_active Application Discontinuation
- 2001-08-23 HU HU0302961A patent/HUP0302961A3/hu unknown
- 2001-08-23 MX MXPA03001536A patent/MXPA03001536A/es unknown
- 2001-08-23 CN CNA018177662A patent/CN1471520A/zh active Pending
- 2001-08-23 EA EA200300066A patent/EA005825B1/ru not_active IP Right Cessation
- 2001-08-23 CZ CZ2003525A patent/CZ2003525A3/cs unknown
- 2001-08-23 SK SK212-2003A patent/SK2122003A3/sk unknown
-
2003
- 2003-01-13 IS IS6675A patent/IS6675A/is unknown
- 2003-02-03 ZA ZA200300922A patent/ZA200300922B/en unknown
- 2003-02-13 BG BG107554A patent/BG107554A/bg unknown
- 2003-02-17 MA MA27041A patent/MA26942A1/fr unknown
- 2003-02-20 NO NO20030802A patent/NO20030802L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20030023769A (ko) | 2003-03-19 |
HUP0302961A2 (hu) | 2003-12-29 |
FR2813308B1 (fr) | 2005-07-01 |
EA005825B1 (ru) | 2005-06-30 |
NO20030802D0 (no) | 2003-02-20 |
NO20030802L (no) | 2003-04-23 |
CZ2003525A3 (cs) | 2003-06-18 |
WO2002016340A1 (fr) | 2002-02-28 |
NZ523724A (en) | 2005-02-25 |
CA2415852A1 (fr) | 2002-02-28 |
JP2004506728A (ja) | 2004-03-04 |
ZA200300922B (en) | 2004-06-22 |
JP5140226B2 (ja) | 2013-02-06 |
OA12360A (fr) | 2006-05-16 |
PL362131A1 (en) | 2004-10-18 |
IL153959A0 (en) | 2003-07-31 |
SK2122003A3 (en) | 2003-09-11 |
US7148240B2 (en) | 2006-12-12 |
WO2002016340A8 (fr) | 2003-07-03 |
IS6675A (is) | 2003-01-13 |
DE60128112T2 (de) | 2007-12-27 |
AU2001286003A1 (en) | 2002-03-04 |
ATE360625T1 (de) | 2007-05-15 |
EP1315710A1 (fr) | 2003-06-04 |
CN1471520A (zh) | 2004-01-28 |
EP1315710B1 (fr) | 2007-04-25 |
EA200300066A1 (ru) | 2003-08-28 |
BR0113347A (pt) | 2004-02-10 |
HUP0302961A3 (en) | 2005-02-28 |
US20040010011A1 (en) | 2004-01-15 |
DE60128112D1 (de) | 2007-06-06 |
MA26942A1 (fr) | 2004-12-20 |
FR2813308A1 (fr) | 2002-03-01 |
MXPA03001536A (es) | 2004-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5603849B2 (ja) | アミノアルキルベンゾイル−ベンゾフランまたはベンゾチオフェン誘導体を含む医薬組成物 | |
BG107554A (bg) | Производни на аминоалкоксибензоил-бензофуран или бензотиофен, метод за получаването им и състави, които ги съдържат | |
CA2340952C (en) | Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists | |
WO2006069788A1 (en) | Organic compounds | |
KR20070007361A (ko) | 1-아미노-프탈라진 유도체, 이의 제조 방법 및 치료적 용도 | |
CA2436130A1 (en) | Substituted indoles and their use as integrin antagonists | |
KR20060127886A (ko) | 5-ht6 수용체-관련 장애의 예방 및 치료에 사용될 수있는, 신규한 벤조퓨란 유도체 | |
JPH0655738B2 (ja) | インダゾール―3―カルボキサミド誘導体及びそれを有効成分とするセロトニン3受容体拮抗剤 | |
SK6112003A3 (en) | Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders | |
CA2146923A1 (en) | Heterocyclic condensed benzoic acid derivatives as 5-ht4 receptor antagonists | |
US5708174A (en) | Heterocyclic-esters or -amides used as 5-HT4 receptor antagonists | |
IL310568A (en) | N-acylhydrazone compounds capable of inhibiting NAV 1.7 and/or NAV 1.8, methods for their preparation, preparations, uses and treatment methods that include them and a kit | |
JP2674199B2 (ja) | 二環式アミン化合物およびその製造法 | |
JP2834506B2 (ja) | 新規チエニルオキシ‐アルキルアミン誘導体、その製法及びこの化合物を含有する医薬 | |
JP4918209B2 (ja) | アミノアルケニルベンゾイル−ベンゾフランまたはベンゾチオフェン誘導体、その製造方法およびそれを含む組成物 | |
KR20110036931A (ko) | 치환된 1-벤질-신놀린-4(1η)-온 유도체, 그의 제조법 및 그의 치료 용도 | |
JPH04210970A (ja) | ベンズアミド誘導体及びその中間体 |